Huida(Shanghai) Biotechnology Co. Ltd..
辉大基因
Huida(Shanghai) Biotechnology Co. Ltd..
Biotech/Healthcare
Hygeia Gene is focused on developing gene therapy drugs based on gene editing. Its activities include developing and optimizing DNA/RNA editing tools, developing and optimizing delivery vectors, developing gene therapy drugs using its proprietary tools and vectors, and carrying out large-scale…
Latest round: Series C (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-05-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.